HELEN OF TROY LTD financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data HELEN OF TROY LTD files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	1,407	1,490	1,564	1,707	2,099	2,223	2,073	2,005	1,908	1,786
Cost of revenue	824	868	923	973	1,171	1,270	1,173	1,056	993	971
Gross profit	573	611	641	734	927	953	899	949	914	816
Research and development	11.8	13.5	13	17.8	53.4	54	47.8	56.5	53.9	54
Selling, general and administrative	401	425	438	512	637	680	660	669	705	709
Operating income	170	169	199	178	281	273	212	261	143	-782
Interest expense	14.4	14	11.7	12.7	12.6	12.8	40.8	53.1	51.9	57.7
Other non-operating income	0.41	0.33	0.34	0.39	0.56	0.26	0.25	1.52	0.84	0.98
Pre-tax income	156	155	188	166	269	260	171	209	91.7	-839
Income tax	11.4	26.6	13.8	13.6	15.5	36.2	28	40.4	-32.1	60.1
Net income	141	44.4	169	152	254	224	143	169	124	-899
EBITDA	206	203	229	216	319	308	256	312	198	-729
EPS, basic	5.11	1.64	6.46	6.06	10.16	9.27	5.98	7.06	5.38	-39.08
EPS, diluted	5.04	1.63	6.41	6.02	10.08	9.17	5.95	7.03	5.37	-39.08
Shares, basic (weighted)	27.5	27.1	26.1	25.1	25	24.1	24	23.9	23	23
Shares, diluted (weighted)	27.9	27.3	26.3	25.3	25.2	24.4	24.1	24	23.1	23

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	23.8	20.7	11.9	24.5	45.1	33.4	29.1	18.5	18.9	18.9
Receivables	229	276	280	348	382	458	378	395	428	361
Inventory	281	252	302	256	482	558	455	396	453	456
Other current assets	9.67	9.55	10.4	9.23	16.2	25.7	24.7	27	26.1	24.1
Total current assets	556	558	605	683	972	1,082	892	844	932	866
Property, plant and equipment	127	124	130	132	137	205	352	337	330	308
Lease right-of-use assets				32.6	32.5	37.8	38.8	36	35.1	49.4
Goodwill	602	602	602	740	740	949	1,066	1,067	1,183	472
Intangible assets	336	303	292	301	357	538	554	537	567	373
Other non-current assets	1.11	20.6	12.5	0.81	3.57	7.89	7.99	15	18	20.2
Total assets	1,813	1,624	1,650	1,904	2,263	2,823	2,914	2,839	3,132	2,116
Accounts payable	106	129	144	153	335	308	191	245	269	256
Accrued liabilities	148	168	165	183	271	272	201	181	161	200
Short-term debt	24.4	1.88	1.88	1.88	1.88	1.88	6.06	6.25	9.38	25
Total current liabilities	289	299	312	339	615	603	412	451	466	505
Long-term debt	461	288	319	337	342	811	928	659	908	756
Lease liabilities				40.9	38.4	43.7	42.7	37.3	39.9	52.9
Other non-current liabilities	17.3	14.7	16.2	20.8	23.4	16.8	13.7	12.4	5.63	0.99
Total liabilities	792	609	653	742	1,024	1,496	1,425	1,201	1,449	1,317
Total debt	486	290	321	339	348	816	937	672	922	786
Paid-in capital	219	231	247	268	283	304	317	349	367	385
Retained earnings	798	780	746	898	965	1,021	1,164	1,284	1,312	413
Other comprehensive income	1.17	0.63	1.19	-7.01	-11.7	0.2	4.95	2.1	2.28	-1.88
Shareholders' equity	1,021	1,014	997	1,162	1,239	1,327	1,489	1,637	1,683	798
Total equity	1,021	1,014	997	1,162	1,239	1,327	1,489	1,637	1,683	798
Total liabilities and equity	1,813	1,624	1,650	1,904	2,263	2,823	2,914	2,839	3,132	2,116
Shares outstanding	27	26.6	24.9	25.2	24.4	23.8	24	23.8	22.9	23.1

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	141	44.4	169	152	254	224	143	169	124	-899
Depreciation and amortization	36.2	33.7	29.9	37.4	37.7	35.8	44.7	51.5	55	53.3
Stock-based compensation	13.9	15.1	22.1	22.9	26.4	34.6	26.8	33.9	21.4	16.9
Deferred income tax	-7.5	21.3	7.64	-5.7	-4.4	-8.87	-2.24	13.2	-76	38
Change in receivables	-4.72	-44.9	-5.81	-60.6	-38.1	-66.8	83.6	-18.7	-23.1	67.9
Change in inventory	17.2	29.4	-50.8	45.5	-221	-45.9	110	58.2	-40.6	-3.2
Change in payables	6.3	23.7	14.2	7.17	176	-43.7	-116	54.4	20.5	-16.5
Cash from operations	229	224	195	271	314	141	208	306	113	171
Capital expenditures	-15.5	-13.6	-26.4	-17.8	-98.7	-78	-175	-36.6	-30.1	-39.2
Acquisitions	-209	0	0	-256	0	-411	-146	0	-229
Cash from investing	-230	35.6	-25.2	-274	-98.7	-439	-319	5.45	-263	-34.4
Debt issued					0	0	250	249	0	250
Debt repaid	-23.8	-25.7	-1.9	-1.9	-1.9	-1.9	-19.8	-247	-6.25	-16.4
Share buybacks	-75.6	-73.1	-217	-10.2	-203	-188	-18.4	-55.2	-103	-1.92
Cash from financing	-201	-262	-179	14.9	-195	286	107	-322	150	-137
Net change in cash	-203	-2.35	-8.87	12.6	20.7	-11.7	-4.31	-10.6	0.37	0.02
Free cash flow	213	211	169	254	215	62.8	33.4	269	83.1	132
Interest paid	9.98	13.5	11.3	12.8	11.6	11.7	43.7	52.5	50.2	55.6
Income taxes paid	16	6.08	4.28	23.3	19.7	22.8	37.1	28.9	40.8	26.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $28.63 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	45.4%	Gross profit / revenue.
Operating margin	-17.3%	Operating income / revenue.
EBITDA margin	-14.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-20.4%	Pre-tax income / revenue.
Net margin	-22.7%	Net income / revenue.
FCF margin	4.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.2%	Cash from operations / revenue.
Return on equity (ROE)	-48.9%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-19.8%	Net income / average total assets.
Return on invested capital (ROIC)	-16.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	36.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-6.4%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-3.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-10.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.2%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-2.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-647.9%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-468.5%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-826.4%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-827.7%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	51.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-6.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-11.4%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	58.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	58.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	-9.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-52.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-18.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-8.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-32.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-10.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-1.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.78x	Current assets / current liabilities.
Quick ratio	0.72x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.05x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.85x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	34.4%	Total debt / total assets.
Liabilities / assets	59.4%	Total liabilities / total assets.
Net debt	$694.5M	Total debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage	-5.60x	Operating income / interest expense.
Working capital	$376.1M	Current assets - current liabilities.
Goodwill and intangibles / assets	40.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$2.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.87x	Revenue / average total assets.
Fixed asset turnover	5.99x	Revenue / average property, plant and equipment.
Inventory turnover	2.12x	Cost of revenue / average inventory.
Days inventory	172 days	365 x average inventory / cost of revenue.
Receivables turnover	5.61x	Revenue / average receivables.
Days sales outstanding	65 days	365 x average receivables / revenue.
Days payables	91 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	147 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	28.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$17.36	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$76.47	Revenue / diluted weighted shares.
FCF per share	$3.39	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.72	Cash from operations / diluted weighted shares.
Book value per share	$36.22	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.11	Tangible book value / shares outstanding.
Cash per share	$0.93	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	2.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$666.9M	Share price x shares outstanding.
Enterprise value	$1.36B	Market cap + total debt - cash - short-term investments.
P/S	0.37x	Market cap / revenue.
P/B	0.79x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	273x	Market cap / tangible book value, when positive.
P/FCF	8.28x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.95x	Market cap / cash from operations, when positive.
EV/Sales	0.75x	Enterprise value / revenue.
EV/FCF	16.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	12.1%	Free cash flow / market cap.
Earnings yield	-61.9%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.3%	(Dividends paid + share buybacks) / market cap.

What was HELEN OF TROY LTD's revenue in fiscal 2026?

HELEN OF TROY LTD reported revenue of $1.79B for fiscal 2026, 6.4% lower than the year before.

Was HELEN OF TROY LTD profitable in fiscal 2026?

No. It reported a net loss of $899.0M.

How much free cash flow did HELEN OF TROY LTD generate in fiscal 2026?

Cash from operations of $171.1M minus capital expenditures of $39.2M left free cash flow of $131.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to HELEN OF TROY LTD